GSK logo

GSK (GSK) Revenue

Annual revenue:

$40.10B+$2.36B(+6.26%)
December 1, 2024

Summary

  • As of today (April 15, 2025), GSK annual revenue is $40.10 billion, with the most recent change of +$2.36 billion (+6.26%) on December 1, 2024.
  • During the last 3 years, GSK annual revenue has risen by +$6.12 billion (+18.03%).
  • GSK annual revenue is now -11.88% below its all-time high of $45.51 billion, reached on December 31, 2007.

Performance

GSK Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

Quarterly revenue:

$10.39B-$33.08M(-0.32%)
December 1, 2024

Summary

  • As of today (April 15, 2025), GSK quarterly revenue is $10.39 billion, with the most recent change of -$33.08 million (-0.32%) on December 1, 2024.
  • Over the past year, GSK quarterly revenue has stayed the same.
  • GSK quarterly revenue is now -21.40% below its all-time high of $13.22 billion, reached on December 31, 2009.

Performance

GSK Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

TTM revenue:

$40.10B+$391.98M(+0.99%)
December 1, 2024

Summary

  • As of today (April 15, 2025), GSK TTM revenue is $40.10 billion, with the most recent change of +$391.98 million (+0.99%) on December 1, 2024.
  • Over the past year, GSK TTM revenue has stayed the same.
  • GSK TTM revenue is now -13.31% below its all-time high of $46.26 billion, reached on March 31, 2010.

Performance

GSK TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

GSK Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.3%0.0%0.0%
3 y3 years+18.0%0.0%0.0%
5 y5 years-7.0%0.0%0.0%

GSK Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+18.0%-0.3%+23.0%at high+14.4%
5 y5-year-7.0%+28.3%-10.8%+882.9%-10.3%+53.1%
alltimeall time-11.9%+2916.7%-21.4%+882.9%-13.3%+7320.6%

GSK Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$40.10B(+6.3%)
$10.39B(-0.3%)
$40.10B(+1.0%)
Sep 2024
-
$10.43B(+4.8%)
$39.71B(+0.3%)
Jun 2024
-
$9.95B(+6.5%)
$39.60B(+2.5%)
Mar 2024
-
$9.34B(-6.6%)
$38.64B(+2.4%)
Dec 2023
$37.74B(+3.9%)
$10.00B(-3.1%)
$37.75B(+3.6%)
Sep 2023
-
$10.32B(+14.8%)
$36.42B(+3.1%)
Jun 2023
-
$8.98B(+6.3%)
$35.32B(+0.8%)
Mar 2023
-
$8.45B(-2.6%)
$35.05B(-3.3%)
Dec 2022
$36.31B(+6.9%)
$8.67B(-5.9%)
$36.24B(-2.3%)
Sep 2022
-
$9.21B(+5.8%)
$37.11B(+0.2%)
Jun 2022
-
$8.71B(-9.7%)
$37.03B(+1.5%)
Mar 2022
-
$9.65B(+1.1%)
$36.48B(-1.6%)
Dec 2021
$33.98B(+8.7%)
$9.54B(+4.4%)
$37.06B(+41.5%)
Sep 2021
-
$9.14B(+12.0%)
$26.20B(-7.2%)
Jun 2021
-
$8.16B(-20.2%)
$28.23B(-4.4%)
Mar 2021
-
$10.23B(-870.4%)
$29.53B(-4.6%)
Dec 2020
$31.26B(-27.5%)
-$1.33B(-111.9%)
$30.95B(-29.2%)
Sep 2020
-
$11.17B(+18.2%)
$43.74B(-0.9%)
Jun 2020
-
$9.45B(-18.9%)
$44.13B(-1.3%)
Mar 2020
-
$11.65B(+1.6%)
$44.71B(+3.9%)
Dec 2019
$43.10B(+4.8%)
$11.46B(-0.9%)
$43.04B(+2.2%)
Sep 2019
-
$11.56B(+15.2%)
$42.13B(+2.5%)
Jun 2019
-
$10.04B(+0.6%)
$41.10B(+0.2%)
Mar 2019
-
$9.98B(-5.4%)
$41.03B(-0.2%)
Dec 2018
$41.12B(+5.5%)
$10.55B(+0.0%)
$41.09B(+1.0%)
Sep 2018
-
$10.54B(+5.8%)
$40.69B(+0.7%)
Jun 2018
-
$9.96B(-0.8%)
$40.41B(+1.5%)
Mar 2018
-
$10.04B(-1.0%)
$39.81B(+2.3%)
Dec 2017
$38.98B(+3.1%)
$10.14B(-1.2%)
$38.91B(+1.9%)
Sep 2017
-
$10.27B(+9.7%)
$38.19B(+1.0%)
Jun 2017
-
$9.36B(+2.3%)
$37.83B(-0.1%)
Mar 2017
-
$9.15B(-2.9%)
$37.86B(+0.6%)
Dec 2016
$37.79B(+3.4%)
$9.42B(-4.9%)
$37.63B(-0.3%)
Sep 2016
-
$9.91B(+5.6%)
$37.74B(+1.1%)
Jun 2016
-
$9.38B(+5.2%)
$37.33B(+1.0%)
Mar 2016
-
$8.92B(-6.5%)
$36.96B(+1.1%)
Dec 2015
$36.56B(-3.6%)
$9.53B(+0.4%)
$36.57B(-0.7%)
Sep 2015
-
$9.49B(+5.3%)
$36.82B(+0.2%)
Jun 2015
-
$9.02B(+5.8%)
$36.75B(-0.9%)
Mar 2015
-
$8.52B(-12.9%)
$37.09B(-2.0%)
Dec 2014
$37.92B(-8.6%)
$9.79B(+3.8%)
$37.86B(-3.5%)
Sep 2014
-
$9.43B(+0.7%)
$39.25B(-1.7%)
Jun 2014
-
$9.36B(+0.8%)
$39.92B(-2.0%)
Mar 2014
-
$9.29B(-16.9%)
$40.73B(-1.8%)
Dec 2013
$41.47B(-1.0%)
$11.18B(+10.7%)
$41.49B(+0.6%)
Sep 2013
-
$10.09B(-0.7%)
$41.23B(-0.5%)
Jun 2013
-
$10.17B(+1.1%)
$41.44B(-0.2%)
Mar 2013
-
$10.05B(-7.9%)
$41.51B(-0.9%)
Dec 2012
$41.88B(-4.6%)
$10.92B(+6.0%)
$41.88B(-0.1%)
Sep 2012
-
$10.31B(+0.7%)
$41.93B(-2.6%)
Jun 2012
-
$10.23B(-1.9%)
$43.06B(-1.7%)
Mar 2012
-
$10.43B(-4.9%)
$43.80B(-0.3%)
Dec 2011
$43.92B(+0.3%)
$10.96B(-4.1%)
$43.92B(-0.9%)
Sep 2011
-
$11.44B(+4.3%)
$44.32B(+2.0%)
Jun 2011
-
$10.96B(+3.9%)
$43.43B(+1.1%)
Mar 2011
-
$10.55B(-7.2%)
$42.94B(-2.1%)
Dec 2010
$43.77B(-1.5%)
$11.37B(+7.7%)
$43.87B(-4.1%)
Sep 2010
-
$10.55B(+0.8%)
$45.72B(-1.1%)
Jun 2010
-
$10.47B(-8.7%)
$46.25B(-0.0%)
Mar 2010
-
$11.47B(-13.2%)
$46.26B(+3.9%)
Dec 2009
$44.43B(-1.3%)
$13.22B(+19.3%)
$44.52B(+5.7%)
Sep 2009
-
$11.08B(+5.8%)
$42.11B(-0.1%)
Jun 2009
-
$10.48B(+7.7%)
$42.14B(-2.5%)
Mar 2009
-
$9.73B(-10.0%)
$43.24B(-3.4%)
Dec 2008
$45.04B(-1.0%)
$10.81B(-2.8%)
$44.76B(-3.1%)
Sep 2008
-
$11.12B(-4.0%)
$46.21B(+0.1%)
Jun 2008
-
$11.58B(+3.0%)
$46.15B(+0.7%)
Mar 2008
-
$11.24B(-8.3%)
$45.84B(+0.7%)
Dec 2007
$45.51B(+6.3%)
$12.26B(+10.8%)
$45.53B(+1.9%)
Sep 2007
-
$11.07B(-1.8%)
$44.68B(+1.1%)
Jun 2007
-
$11.27B(+3.1%)
$44.18B(+1.5%)
Mar 2007
-
$10.93B(-4.2%)
$43.55B(+1.8%)
Dec 2006
$42.80B(+8.6%)
$11.41B(+7.9%)
$42.80B(+2.6%)
Sep 2006
-
$10.57B(-0.6%)
$41.70B(+1.9%)
Jun 2006
-
$10.63B(+4.5%)
$40.92B(+2.3%)
Mar 2006
-
$10.18B(-1.3%)
$40.01B(+1.7%)
Dec 2005
$39.40B(+7.6%)
$10.31B(+5.3%)
$39.35B(+1.4%)
Sep 2005
-
$9.79B(+0.7%)
$38.80B(+2.2%)
Jun 2005
-
$9.72B(+2.1%)
$37.97B(+2.0%)
Mar 2005
-
$9.52B(-2.4%)
$37.23B(+1.6%)
DateAnnualQuarterlyTTM
Dec 2004
$36.61B(+4.6%)
$9.76B(+8.9%)
$36.62B(+1.7%)
Sep 2004
-
$8.96B(-0.2%)
$36.00B(+0.5%)
Jun 2004
-
$8.98B(+0.7%)
$35.84B(+1.0%)
Mar 2004
-
$8.92B(-2.4%)
$35.48B(+1.3%)
Dec 2003
$35.02B(+9.9%)
$9.14B(+3.9%)
$35.02B(+0.7%)
Sep 2003
-
$8.80B(+2.1%)
$34.79B(+3.0%)
Jun 2003
-
$8.62B(+1.9%)
$33.77B(+2.1%)
Mar 2003
-
$8.46B(-5.1%)
$33.07B(+3.7%)
Dec 2002
$31.88B(+7.8%)
$8.91B(+14.6%)
$31.89B(+2.4%)
Sep 2002
-
$7.78B(-1.8%)
$31.15B(+1.9%)
Jun 2002
-
$7.92B(+8.6%)
$30.55B(+2.1%)
Mar 2002
-
$7.29B(-10.7%)
$29.91B(+1.2%)
Dec 2001
$29.58B(+7.9%)
$8.17B(+13.7%)
$29.57B(+3.1%)
Sep 2001
-
$7.18B(-1.3%)
$28.69B(+2.3%)
Jun 2001
-
$7.28B(+4.8%)
$28.05B(+1.2%)
Mar 2001
-
$6.95B(-4.6%)
$27.71B(+1.4%)
Dec 2000
$27.40B(+99.5%)
$7.28B(+11.2%)
$27.33B(+15.0%)
Sep 2000
-
$6.55B(-5.6%)
$23.77B(+13.9%)
Jun 2000
-
$6.94B(+5.6%)
$20.87B(+20.5%)
Mar 2000
-
$6.57B(+76.8%)
$17.32B(+23.4%)
Dec 1999
$13.74B(+3.8%)
$3.72B(+1.9%)
$14.04B(+1.9%)
Sep 1999
-
$3.65B(+7.6%)
$13.78B(+1.8%)
Jun 1999
-
$3.39B(+3.1%)
$13.53B(+1.5%)
Mar 1999
-
$3.29B(-5.0%)
$13.34B(+0.8%)
Dec 1998
$13.23B(+1.2%)
$3.46B(+1.7%)
$13.23B(+3.2%)
Sep 1998
-
$3.40B(+6.5%)
$12.83B(+1.2%)
Jun 1998
-
$3.19B(+0.5%)
$12.68B(-0.8%)
Mar 1998
-
$3.18B(+4.1%)
$12.78B(-1.2%)
Dec 1997
$13.07B(+0.3%)
$3.05B(-6.1%)
$12.94B(-16.0%)
Sep 1997
-
$3.25B(-1.1%)
$15.39B(-3.8%)
Jun 1997
-
$3.29B(-1.4%)
$16.01B(+0.6%)
Mar 1997
-
$3.34B(-39.4%)
$15.91B(+0.5%)
Dec 1996
$13.03B(-21.3%)
$5.51B(+42.5%)
$15.82B(+53.4%)
Sep 1996
-
$3.87B(+21.3%)
$10.31B(+14.5%)
Jun 1996
-
$3.19B(-2.1%)
$9.01B(+5.8%)
Mar 1996
-
$3.26B(+27.0%)
$8.51B(-18.1%)
Dec 1995
$16.56B(+61.9%)
-
-
Sep 1995
-
$2.56B(-4.8%)
$10.40B(+0.3%)
Jun 1995
-
$2.69B(+6.5%)
$10.37B(+7.4%)
Jun 1995
$10.23B(+20.8%)
-
-
Mar 1995
-
$2.53B(-3.3%)
$9.65B(+2.9%)
Dec 1994
-
$2.61B(+3.3%)
$9.38B(+5.6%)
Sep 1994
-
$2.53B(+28.2%)
$8.89B(+5.2%)
Jun 1994
$8.47B(+5.6%)
$1.97B(-12.7%)
$8.45B(+3.6%)
Mar 1994
-
$2.26B(+6.6%)
$8.16B(+0.4%)
Dec 1993
-
$2.12B(+1.3%)
$8.12B(+4.0%)
Sep 1993
-
$2.09B(+24.6%)
$7.81B(+3.1%)
Jun 1993
$8.01B(+11.2%)
$1.68B(-24.6%)
$7.58B(+4.8%)
Mar 1993
-
$2.23B(+23.3%)
$7.23B(+3.5%)
Dec 1992
-
$1.81B(-2.9%)
$6.98B(-0.6%)
Sep 1992
-
$1.86B(+39.8%)
$7.02B(-0.2%)
Jun 1992
$7.21B(+14.3%)
$1.33B(-32.9%)
$7.04B(-5.5%)
Mar 1992
-
$1.98B(+7.2%)
$7.44B(+6.7%)
Dec 1991
-
$1.85B(-1.3%)
$6.97B(+7.0%)
Sep 1991
-
$1.87B(+7.8%)
$6.52B(+8.4%)
Jun 1991
$6.30B(+21.8%)
$1.74B(+14.9%)
$6.01B(+3.3%)
Mar 1991
-
$1.51B(+8.7%)
$5.82B(+3.8%)
Dec 1990
-
$1.39B(+1.5%)
$5.61B(+3.7%)
Sep 1990
-
$1.37B(-11.5%)
$5.41B(+3.5%)
Jun 1990
$5.17B(+17.3%)
$1.55B(+19.3%)
$5.23B(+5.3%)
Mar 1990
-
$1.30B(+8.8%)
$4.96B(+6.0%)
Dec 1989
-
$1.19B(+0.5%)
$4.68B(+4.1%)
Sep 1989
-
$1.19B(-7.6%)
$4.50B(+3.9%)
Jun 1989
$4.41B(+22.2%)
$1.29B(+26.2%)
$4.33B(+2.3%)
Mar 1989
-
$1.02B(+1.1%)
$4.23B(+3.8%)
Dec 1988
-
$1.01B(-1.1%)
$4.08B(+5.0%)
Sep 1988
-
$1.02B(-14.4%)
$3.89B(+4.2%)
Jun 1988
$3.61B(+36.0%)
$1.19B(+37.7%)
$3.73B(+13.1%)
Mar 1988
-
$863.72M(+6.1%)
$3.30B(+4.7%)
Dec 1987
-
$814.42M(-5.5%)
$3.15B(+6.1%)
Sep 1987
-
$862.23M(+13.6%)
$2.97B(+6.8%)
Jun 1987
$2.66B(+29.0%)
$758.67M(+6.2%)
$2.78B(+12.3%)
Mar 1987
-
$714.30M(+12.9%)
$2.47B(+7.5%)
Dec 1986
-
$632.59M(-6.0%)
$2.30B(+3.8%)
Sep 1986
-
$672.76M(+48.0%)
$2.22B(+6.3%)
Jun 1986
$2.06B(+42.0%)
$454.71M(-16.1%)
$2.09B(+27.9%)
Mar 1986
-
$542.04M(-1.2%)
$1.63B(+49.8%)
Dec 1985
-
$548.45M(+1.5%)
$1.09B(+101.5%)
Sep 1985
-
$540.44M
$540.44M
Jun 1985
$1.45B(+9.1%)
-
-
Jun 1984
$1.33B
-
-

FAQ

  • What is GSK annual revenue?
  • What is the all time high annual revenue for GSK?
  • What is GSK annual revenue year-on-year change?
  • What is GSK quarterly revenue?
  • What is the all time high quarterly revenue for GSK?
  • What is GSK quarterly revenue year-on-year change?
  • What is GSK TTM revenue?
  • What is the all time high TTM revenue for GSK?
  • What is GSK TTM revenue year-on-year change?

What is GSK annual revenue?

The current annual revenue of GSK is $40.10B

What is the all time high annual revenue for GSK?

GSK all-time high annual revenue is $45.51B

What is GSK annual revenue year-on-year change?

Over the past year, GSK annual revenue has changed by +$2.36B (+6.26%)

What is GSK quarterly revenue?

The current quarterly revenue of GSK is $10.39B

What is the all time high quarterly revenue for GSK?

GSK all-time high quarterly revenue is $13.22B

What is GSK quarterly revenue year-on-year change?

Over the past year, GSK quarterly revenue has changed by $0.00 (0.00%)

What is GSK TTM revenue?

The current TTM revenue of GSK is $40.10B

What is the all time high TTM revenue for GSK?

GSK all-time high TTM revenue is $46.26B

What is GSK TTM revenue year-on-year change?

Over the past year, GSK TTM revenue has changed by $0.00 (0.00%)
On this page